New Trends in Pharma Industry–制药厂的新招
GSK is considering submitting patents on future cancer drugs it develops to the United Nation’s Medicines Patent Pool (MPP), in an effort to address “the increasing burden of cancer in developing countries.” The MPP negotiates large scale licensing agreements between drug developers and multiple generics manufacturers — enabling greater access to medicines for a larger …